Webinar: A New Approach to Treating Generalized Myasthenia Gravis: KYY-101 CAR T-cell Therapy
Автор: Myasthenia Gravis Foundation of America
Загружено: 2025-12-09
Просмотров: 250
Описание: Kyverna’s investigational CAR T-cell therapy, KYV-101, is a type of immunotherapy that is different than current treatments for generalized myasthenia gravis (gMG). It is a single dose and works by using a person’s own immune cells to fight disease. During this webinar, we’ll learn more about how CAR T-cell therapies work and discuss an ongoing phase 3 clinical study, called KYSA-6, which is evaluating KYV-101 for patients living with gMG. This study is open to those with AChR or MuSK+ MG; for full criteria, visit clinicaltrials.gov.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: